Enzo Biochem Inc. (ENZ) Business Metric Overview

AI Score

Unlock

AI Score

Our AI model analyzes fundamental, technical, and statistical indicators to predict the probability of a bullish trend over the next three months.

We regularly update and refine our models to deliver the most reliable forecasts for you.

Bullish Probability	Sentiment	Score
+80%	Strong Buy	10
+75%	Buy	9
+70%	Buy	8
+60%	Buy	7
+50%	Hold	6
+45%	Hold	5
+40%	Hold	4
+35%	Sell	3
+30%	Sell	2
+20%	Strong Sell	1

Enzo Biochem Inc. (ENZ)

AI Score

Unlock

AI Score

Bullish Probability	Sentiment	Score
+80%	Strong Buy	10
+75%	Buy	9
+70%	Buy	8
+60%	Buy	7
+50%	Hold	6
+45%	Hold	5
+40%	Hold	4
+35%	Sell	3
+30%	Sell	2
+20%	Strong Sell	1

undefined

undefined%

At close: undefined

0.76

5.18%

After-hours Jan 06, 2025, 07:16 PM EST

Enzo Biochem Inc. Revenue Breakdown

Quarter	Jul 31, 2022
Consolidated Member Revenue	20.28M
Consolidated Member Revenue Growth	n/a

Revenue by Geography

Quarter	Jul 31, 2024	Jul 31, 2023	Jul 31, 2022	Jul 31, 2021
Asia Pacific Revenue	3.86M	4.06M	19.78M	102.60M
Asia Pacific Revenue Growth	-5.02%	-79.47%	-80.72%	n/a
Europe Revenue	8.56M	8.45M	4.29M	4.74M
Europe Revenue Growth	+1.33%	+96.74%	-9.49%	n/a
United States Revenue	19.49M	18.55M	8.57M	10.39M
United States Revenue Growth	+5.06%	+116.51%	-17.50%	n/a

Operating Expense Breakdown

Quarter	Oct 31, 2024	Jul 31, 2024	Apr 30, 2024	Jan 31, 2024	Oct 31, 2023	Jul 31, 2023	Apr 30, 2023	Jan 31, 2023	Oct 31, 2022	Jul 31, 2022	Apr 30, 2022	Jan 31, 2022	Oct 31, 2021	Jul 31, 2021	Apr 30, 2021	Jan 31, 2021	Oct 31, 2020	Jul 31, 2020	Apr 30, 2020	Jan 31, 2020	Oct 31, 2019	Jul 31, 2019	Apr 30, 2019	Jan 31, 2019	Oct 31, 2018	Jul 31, 2018	Apr 30, 2018	Jan 31, 2018	Oct 31, 2017	Jul 31, 2017	Apr 30, 2017	Jan 31, 2017	Oct 31, 2016	Jul 31, 2016	Apr 30, 2016	Jan 31, 2016	Oct 31, 2015	Jul 31, 2015	Apr 30, 2015	Jan 31, 2015
Selling, General, and Administrative Revenue	4.88M	7.80M	4.48M	5.07M	7.01M	-8.08M	12.02M	11.81M	11.45M	16.75M	11.44M	14.47M	11.05M	11.80M	12.08M	11.01M	10.01M	10.07M	11.06M	10.69M	11.14M	10.88M	10.92M	11.50M	10.97M	11.48M	11.03M	11.07M	10.89M	10.87M	10.50M	11.16M	11.47M	11.21M	10.87M	11.28M	10.22M	10.97M	10.15M	9.67M
Selling, General, and Administrative Revenue Growth	-37.45%	+74.26%	-11.62%	-27.67%	-186.69%	-167.24%	+1.78%	+3.15%	-31.62%	+46.36%	-20.90%	+30.89%	-6.31%	-2.37%	+9.71%	+9.98%	-0.53%	-8.99%	+3.44%	-4.00%	+2.40%	-0.38%	-5.02%	+4.80%	-4.43%	+4.12%	-0.41%	+1.64%	+0.20%	+3.49%	-5.94%	-2.69%	+2.34%	+3.16%	-3.64%	+10.32%	-6.77%	+8.10%	+4.92%	n/a
Research and Development Revenue	562.00K	607.00K	605.00K	580.00K	849.00K	502.00K	975.00K	1.43M	996.00K	1.07M	1.13M	820.00K	744.00K	864.00K	836.00K	806.00K	746.00K	1.17M	1.16M	1.06M	1.05M	833.00K	781.00K	833.00K	728.00K	852.00K	799.00K	812.00K	747.00K	857.00K	766.00K	483.00K	822.00K	914.00K	882.00K	861.00K	867.00K	916.00K	809.00K	834.00K
Research and Development Revenue Growth	-7.41%	+0.33%	+4.31%	-31.68%	+69.12%	-48.51%	-31.87%	+43.67%	-6.92%	-5.56%	+38.17%	+10.22%	-13.89%	+3.35%	+3.72%	+8.04%	-36.02%	+0.26%	+9.20%	+1.04%	+26.53%	+6.66%	-6.24%	+14.42%	-14.55%	+6.63%	-1.60%	+8.70%	-12.84%	+11.88%	+58.59%	-41.24%	-10.07%	+3.63%	+2.44%	-0.69%	-5.35%	+13.23%	-3.00%	n/a